Advertisement

PharmacoEconomics & Outcomes News

, Volume 836, Issue 1, pp 10–10 | Cite as

Dramatic price rises of MS therapies in the US big concern

Non-clinical study
  • 5 Downloads

References

  1. 1.
    San-Juan-Rodriguez A, et al. Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D. JAMA Neurology : 26 Aug 2019. Available from: URL: http://doi.org/10.1001/jamaneurol.2019.2711
  2. 2.
    Hartung DM, et al. Addressing the Rising Prices of Disease-Modifying Therapies for Multiple Sclerosis. JAMA Neurology : 26 Aug 2019. Available from: URL: http://doi.org/10.1001/jamaneurol.2019.2445

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations